Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...
The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...
Hosted on MSN11h
Bowel cancer is rising in young people – here's what your poo can say about your healthNew research has found that UK bowel cancer death rates are forecast to rise by a third amongst young British adults – with obesity and binge drinking thought ... The Bristol Stool Chart can be a ...
Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive Versant's backing in ...
Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 202 ...
Ad Age is counting down to Super Bowl LIX. In the weeks leading up to the game, which will air on Fox on Feb. 9, Ad Age will bring you breaking news, analysis and first looks at the high-stakes Big ...
Alarming development among 18-year-olds, the proportion of those fit for military service continues to fall: almost one in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback